Intravenous Infusions (XGHA:IIL) Land And Improvements: GHS0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XGHA:IIL Intravenous Infusions Ltd XGHA:IIL
3 GF Score
Price GHS0.55
View Full Analysis

What is Intravenous Infusions Land And Improvements?

Intravenous Infusions XGHA:IIL -3.51% 3 Land And Improvements is GHS0.00 Mil as of . 20. GuruFocus rates XGHA:IIL with a GF Score™ of 3/100.

Intravenous Infusions's land and improvements for the quarter that ended in . 20 was GHS0.00 Mil.

Intravenous Infusions Land And Improvements Historical Data

* Premium members only.

The historical data trend for Intravenous Infusions's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intravenous Infusions Land And Improvements Chart

Intravenous Infusions Annual Data
Trend
Land And Improvements

Intravenous Infusions Semi-Annual Data
Land And Improvements
XGHA:IIL
3GF Score
Intravenous Infusions Ltd XGHA:IIL
Land And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intravenous Infusions Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Frequently Asked Questions Learn more about Land And Improvements →
What does a Land And Improvements of GHS0.00 Mil mean?
Intravenous Infusions (XGHA:IIL) has a Land And Improvements of GHS0.00 Mil as of . 20. Land and improvements records the total value of a company's land and improvements to it. View historical data on Intravenous Infusions and its competitors.
Is Intravenous Infusions' Land And Improvements too high?
Intravenous Infusions' current Land And Improvements is GHS0.00 Mil. Overall, Intravenous Infusions has a GF Score™ of 3/100, reflecting its overall financial health beyond just this single metric.
How does Intravenous Infusions' Land And Improvements compare to PTLF and PCYN?
Intravenous Infusions' Land And Improvements of GHS0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Land And Improvements for a Drug Manufacturers company?
A good Land And Improvements depends on the Drug Manufacturers industry context. However, Land And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Land And Improvements mean?
A high Land And Improvements can signal that a stock is expensive relative to its fundamentals. Land and improvements records the total value of a company's land and improvements to it. View historical data on Intravenous Infusions and its competitors. Intravenous Infusions's current Land And Improvements is GHS0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intravenous Infusions stock overvalued right now?
Intravenous Infusions (XGHA:IIL) has a current Land And Improvements of GHS0.00 Mil. The current Land And Improvements is GHS0.00 Mil. Intravenous Infusions' overall GF Score™ is 3/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Land And Improvements calculated?
Land And Improvements is calculated from a company's financial statements. For Intravenous Infusions (XGHA:IIL), the current Land And Improvements is GHS0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Intravenous Infusions Business Description

Address Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.
3GF Score

Get the complete analysis for XGHA:IIL

Land And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

GHS0.55
Price